Latest Headlines

Latest Headlines

Verastem gears up for companion Dx mesothelioma treatment trial

Verastem's quest to develop drugs that block cell signaling pathways that cancer stem cells need to survive hits a major milestone in mid-2013, when it launches a 350-patient clinical trial of a potential companion biomarker test for its investigative mesothelioma drug treatment.

LabCorp inks companion diagnostic deal with Verastem

Verastem has signed on with LabCorp to validate biomarkers and develop companion diagnostics for VS-6063, the company's in-development mesothelioma treatment.

MIT researchers help biotech start-up attack cancer stem cells

A trio of top researchers at MIT have contributed their insights on cancer stem cells to help launch Verastem, a biotech company that will pursue new drugs specifically targeting a culprit that